Form 4: Arvinas Inc. Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Angela M. Cacace, Chief Scientific Officer of Arvinas Inc., sold shares of common stock to cover tax withholding obligations related to vesting of restricted stock units.
Summary
- On February 24, 2025, Angela M. Cacace, the Chief Scientific Officer of Arvinas Inc. (ARVN), sold 3,061 shares of common stock at $16.75 per share and 1,146 shares at $16.55 per share.
- These sales were executed automatically by Arvinas to cover tax withholding obligations associated with the vesting and settlement of restricted stock units (RSUs).
- The sales relate to the vesting of one-half of the RSUs granted on February 23, 2024, and one-quarter of the RSUs granted on February 22, 2023.
- Following these transactions, Cacace directly owns 97,231 shares of Arvinas common stock, which includes 494 shares purchased under the company's 2018 Employee Stock Purchaser Plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing relates to routine stock sales for tax purposes and doesn't indicate any significant change in the executive's confidence in the company.
Industry Context
Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.
Key Dates
| Date | Description |
|---|---|
| 2023-02-22 | Date of grant for one-quarter of the reporting person's RSUs. |
| 2024-02-23 | Date of grant for one-half of the reporting person's RSUs. |
| 2025-02-24 | Date of stock sale transactions. |
| 2025-02-25 | Date of signature on the Form 4 filing. |
Keywords
Arvinas, ARVN, Angela M. Cacace, Chief Scientific Officer, Form 4, Stock Sale, Restricted Stock Units, RSU, Tax Withholding, Employee Stock Purchaser Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.